Postoperative respiratory complications increase healthcare utilization (e.g. hospital length of stay, unplanned admission to intensive care or high-dependency units, and hospital readmission), mortality, and adverse discharge to a nursing home. Furthermore, they are associated with significant costs. Center-specific treatment guidelines may reduce risks and can be guided by a local champion with multidisciplinary involvement. Patients should be risk-stratified before surgery and offered anesthetic choices (such as regional anesthesia). It is established that laparoscopic surgery improves respiratory outcomes over open surgery but requires tailored anesthesia/ventilation strategies (positive end-expiratory pressure utilization and low inflation pressure). Interventions to optimize treatment include judicious use of intensive care, moderately restrictive fluid therapy, and appropriate neuromuscular blockade with adequate reversal. Patients' ventilatory drive should be kept within a normal range wherever possible. High-dose opioids should be avoided, while volatile anesthetics appear to be lung protective. Tracheal extubation should occur in the reverse Trendelenburg position, and postoperative continuous positive airway pressure helps prevent airway collapse. In combination, all of these interventions facilitate early mobilization. This work was supported by an unrestricted grant from Jeff and Judy Buzen to develop personalized perioperative care to ME.
Introduction
Postoperative respiratory complications commonly occur, with an incidence of up to approximately 10% in general surgery [1] [2] [3] [4] (even higher with thoracic surgery 5 ). Complications include postextubation hypoxemia, reintubation, acute respiratory failure, pulmonary edema, pneumonia, and atelectasis. These increase hospital length of stay, unplanned ICU admissions, hospital readmissions, mortality, and costs [6] [7] [8] [9] [10] [11] . For example, respiratory failure after abdominal surgery can increase 30-day mortality 10-fold 6 .
Pathophysiology
Pathologically, we can characterize respiratory complications as being due to respiratory muscle dysfunction or as a primary airway disease. The latter can in turn be subdivided into upper airway-related complications, such as reintubation of an obstructive sleep apnea (OSA) patient, or pulmonary complications, such as pulmonary edema.
Both respiratory muscle dysfunction and airway disease can develop as a consequence of an imbalance in ventilatory drive. Both increases and decreases in ventilatory drive are potentially harmful and may, for example, increase the risk of aspiration by negatively affecting the interaction between breathing and swallowing ( Figure 1 ). Sedation due to opioid and anxiolytic therapy commonly leads to upper airway dysfunction, resulting in insufficient respiration (hypopnea/apnea), but also affects the breathing-swallowing coordination and pharyngeal muscle strength, both of which contribute to pharyngeal dysfunction and increased risk of aspiration 12 . In turn, an increase in respiratory drive (e.g. during hypercapnic respiratory failure) can lead to high transpulmonary pressure during inspiration, which increases lung stress. Supplementation of inhaled carbon dioxide was shown to reverse upper airway collapsibility induced by propofol 13 , but excessive hypercapnia increases the likelihood of pathological swallowing 14 . Thus, perioperative physicians need to balance their interventions to keep ventilatory drive within normal limits. Upper airway collapse can lead to desaturation, atelectasis, and respiratory failure. Patency of the upper airway depends on competing dilating versus collapsing forces 15, 16 . The former includes the pharyngeal dilator muscles (genioglossus and tensor palatini) and caudal traction on the airway from lung expansion (which can be improved by positive end-expiratory pressure [PEEP] ). Sedatives, opioids, or even delirium can decrease airway dilator muscle tone. Dilating forces are influenced by atelectasis or the inevitable supine position of surgery. In contrast, collapsing forces include external pressure from surrounding soft tissue, which is increased in the presence of edema, obesity, blood clots, and tumors or in the supine position.
Remarkably, perhaps, significant postoperative pulmonary edema is reported in up to 1-2% of patients 9 , and causes include negative pressure pulmonary edema, fluid shifts, and, rarely, neurogenic edema in acute hypertension or after cerebral injury 17 .
More common than edema is atelectasis, and its pathophysiology starts minutes after induction 18 . A reduced regional transpulmonary pressure in dependent lung areas is accentuated by inflam- Figure 1 . Effects of respiratory drive on perioperative respiratory complication risk. Changes in respiratory drive play a key role in the development of postoperative respiratory complications. Both increases and decreases in respiratory drive are potentially harmful and can affect the risk of aspiration. In addition, an increase in respiratory drive, for example during hypercapnic respiratory failure, can lead to high transpulmonary pressure during inspiration, which increases lung stress. Sedation commonly leads to upper airway dysfunction, resulting in insufficient respiration (hypopnea/apnea) but also affects the breathing-swallowing coordination and pharyngeal muscle strength, both of which contribute to pharyngeal dysfunction and increased risk of aspiration 12 . Supplementation of inhaled carbon dioxide was shown to reverse upper airway collapsibility induced by propofol 13 , but excessive hypercapnia increases the likelihood of pathological swallowing 14 . Thus, perioperative physicians need to balance their interventions to keep ventilator drive within normal limits. ARDS, acute respiratory distress syndrome. mation induced by surgery, bacterial translocation, chest wall restriction, and cephalad diaphragm displacement by surgical retraction. This extends postoperatively, such that a restrictive pattern worsens respiratory mechanics and gas exchange. Pain, high inflation driving pressures, and inflammation all contribute.
Ventilator-induced lung injury has multiple causes. In addition to barotrauma, reduced lung compliance in unrecruited areas causes overinflation of aerated lung tissue in nondependent areas with subsequent "volutrauma". Cyclical effects lead to "atelectotrauma". As mentioned above, the release of local proinflammatory mediators also contributes to lung injury "biotrauma" 19, 20 .
Recommendations for patient management
Modifiable perioperative factors in patient management are shown in Table 1 . All the aforementioned pathophysiological processes make the optimization of ventilation as a protective strategy logical. What is really important, though, is preoperative screening and patient selection. The Score for Prediction of Postoperative Respiratory Complications (SPORC) is useful in this regard, as it relates the probability of re-intubation to ASA score, emergency surgery, heart failure, and pulmonary disease 21 .
However, SPORC does not include factors such as smoking.
Smoking is associated with increased risk of postoperative respiratory complications, and smoking cessation before surgery has been shown to decrease adverse respiratory events 22, 23 . Interestingly, it has been found that an increased average minimum alveolar concentration of volatile anesthetics, including nitrous oxide, improves 30-day mortality and the risk of pulmonary complications 33 . The adverse influence of neuromuscular blocking agents (NMBAs) is now well established, especially when associated with inadequate reversal [34] [35] [36] [37] 44, 45 . Monitoring of NMBAs along with reversal guided by neuromuscular transmission is now mandatory according to minimum monitoring guidelines in the UK 46 . The choice of reversal agent remains controversial; while sugammadex was shown to reduce the incidence of postoperative residual paralysis compared with neostigmine in one randomized controlled trial 47 , a recent multicenter observational study (POPULAR trial) found no association between the reversal agent used and postoperative respiratory complications 37 .
With regard to fluid administration, it is the most-restrictive and the most-liberal strategies that have been associated with respiratory complications, whereas moderate regimens appear to be optimal 38, 39, 48 . Pain is an adverse factor for respiratory complications, but very high doses of opioids are also potentially harmful 40 . Neuraxial blockade may reduce postoperative morbidity and mortality in subpopulations 31, 49 , and laparoscopic surgery, which may contribute to better analgesia, further appears beneficial 30 . Good pain relief also promotes early mobilization, which shortens patients' length of stay 50 . Monitoring is important in the detection of early signs of respiratory complications and the decision to admit and observe a patient in the ICU as opposed to the PACU 51 .
Conclusions
There is a considerable literature base supporting the individual results highlighted above. What is emerging is the need for the development and implementation of center-specific guidelines, based on algorithms, coupled with key performance indicators developed by multidisciplinary teams (Figure 2 ). This can form the basis of a continuous quality improvement program. An important driver in achieving this goal is a local champion or "facilitator", who can lead the integration of the needed processes.
Grant information
This work was supported by an unrestricted grant from Jeff and Judy Buzen to develop personalized perioperative care to ME.
The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. In a multidisciplinary approach, center-specific guidelines, algorithms, and performance indicators should be developed. Their implementation (red solid arrows) can be facilitated by a local "champion". Factors concerning the preoperative, intraoperative, and postoperative period need to be addressed, as each can have an impact on outcomes. Periodic review and assessment of processes and outcomes (green dotted arrows) will ensure continuous improvement. CPAP, continuous positive airway pressure; FiO2, fraction of inspired oxygen; ICU, intensive care unit; NMBA, neuromuscular blocking agent.
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